Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use

Reuters2021-06-12

HANOI, June 12 (Reuters) - Vietnam has approved the COVID-19 vaccine jointly made by Pfizer and BioNTech for domestic emergency use, the government said on Saturday.

It is the fourth vaccine to be endorsed in the Southeast Asian country that is tackling a new outbreak.

Vietnam, which has previously approved the AstraZeneca vaccine, Russia's Sputnik V and China's Sinopharm vaccine, said it is seeking to procure 31 million doses of the Pfizer/BioNTech version for delivery in the next quarter.

Vietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.

The health ministry also said on Saturday it was in talks with an unidentified U.S. manufacturer to producer a one-dose vaccine with a view to producing 100 million-200 million shots per year.

Vietnam, with a population of around 98 million, has recorded a total of 10,241 coronavirus cases, with 58 deaths, since the pandemic began. Its domestic inoculation started in March.

At least 1.4 million people in Vietnam have had one dose of a COVID-19 vaccine, while 53,127 have been fully vaccinated, according to official data.

(Reporting by Phuong Nguyen; Editing by Toby Chopra and Mike Harrison)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
108